Notably, natural killer group 2A (NKG2A)+ CD8+ T cells have been shown to be enriched in CRC, and obstructing NKG2A (or its ligands) enhances the cytotoxic response of these T cells toward CRC cells [66]. This evidence concerns the gene KLRC1 and colorectal carcinoma.